Drugmakers Ensnared in Brexit Seek Sway Over Medicine Cabinets

Drugmakers Ensnared in Brexit Seek Sway Over Medicine Cabinets

June 28, 2016, Bloomberg

Grant Castle is quoted in a Bloomberg article regarding the implications of Brexit on the future of the pharmaceutical industry and the drug approval process. According to Castle, the best that the UK regulator could hope for would be an observer status on European Medicines Agency committees. That loss of influence could make the UK less appealing, because it “wouldn’t be the same pull to pharmaceutical companies that they once were,” he says.